CVRdatabase
Menu

Vilas Pharmaceutical Services ApS

Private limited companyCVR 35648275RingstedActive

Vilas Pharmaceutical Services ApS is a private limited company, based in Ringsted, active in business and other management consultancy activities, founded in 2014. Net profit fell 24% from 2025 to 2026, ending at DKK 77,629.

Follow
PDF reportCompare

Key figures · financial year 2026

Gross profitDKK 1.1m−3.6% vs. 2025
Net profitDKK 77,629−23.8% vs. 2025
EquityDKK 686k−7.7% vs. 2025
Employees2latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit fell 4% (2025 → 2026), to DKK 1.1m.
  • Net profit fell 24% (2025 → 2026), to DKK 77,629.
  • Equity fell 8% (2025 → 2026), to DKK 686k.

Registrations, last 24 months

  • 01/01/2025: Industry changed to Business and other management consultancy activities (702000)

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 100kDKK 200kDKK 300kDKK 400kDKK 500kDKK 600kDKK 700kDKK 800k202120222023202420252026
EquityNet profit
Financial figures for Vilas Pharmaceutical Services ApS
202120222023202420252026Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit9787121,2871,0521,1041,064−3.6%
Operating profit (EBIT)–40481196–––
Profit before tax37847452212148116−21.4%
Net profit2933034516710278−23.8%
Total assets1,141711962891886782−11.8%
Equity616533764763743686−7.7%
Liabilities52116519211513496−28.3%
Cash and cash equivalents51352242339303182−40%
Average number of employees1111110%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 200kDKK 400kDKK 600kDKK 800kDKK 1mDKK 1.2mDKK 1.4m202120222023202420252026
Gross profitMedian, the industry (2,370 companies)

Signals from the financial statements

calculated from the 2026 figures

  • Profit for five years in a row

    Net result has been positive in 2022–2026.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Vilas Pharmaceutical Services ApS
Financial yearPeriodPublishedFigures forDocuments
202601/06/2025 – 31/05/202616/06/2026The companyPDF not statedXBRL
202501/06/2024 – 31/05/202511/06/2025The companyPDF not statedXBRL
202401/06/2023 – 31/05/202405/07/2024The companyPDFXBRL
202301/06/2022 – 31/05/202322/08/2023The companyPDFXBRL
202201/06/2021 – 31/05/202215/09/2022The companyPDFXBRL
202101/06/2020 – 31/05/202129/10/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0112208/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

2,370 companies in the database

Comparison with the other companies in business and other management consultancy activities based on the latest financial year.

Gross profitDKK 1.1mNo. 1322 of 2,358
Better than 44% of the companies in the industry
EquityDKK 686kNo. 1348 of 2,369
Better than 43% of the companies in the industry
Number of employees2No. 1568 of 2,370
Better than 34% of the companies in the industry

Industry median: gross profit DKK 1.3m, net profit DKK 170k, equity DKK 974k, 2 employees.

DKK 100kDKK 1.6mDKK 26.5mDKK 431.1mDKK 2.8bnHere
Distribution of gross profit for 2,031 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 43,661of 69,742
Better than 37%
No. 38,472of 69,964
Better than 45%
Same industry and fewer than 20 employees2,220 companies in the comparison
No. 1,185of 2,210
Better than 46%
No. 1,218of 2,219
Better than 45%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 22,814of 33,588
Better than 32%
No. 17,958of 33,687
Better than 47%
All companies of type ApS66,508 companies in the comparison
No. 42,038of 66,379
Better than 37%
No. 34,342of 66,505
Better than 48%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Business and other management consultancy activities
Gross profit
  1. Vilas Pharmaceutical Services ApSDKK 1.1m
  2. COWI Holding A/SDKK 7bn
  3. Accenture A/SDKK 1.1bn
Net profit
  1. Vilas Pharmaceutical Services ApSDKK 77,629
  2. COWI Holding A/SDKK 374m
  3. Accenture A/SDKK 116.1m
Equity
  1. Vilas Pharmaceutical Services ApSDKK 686k
  2. COWI Holding A/SDKK 2bn
  3. Accenture A/SDKK 642m
Employees
  1. Vilas Pharmaceutical Services ApS2
  2. COWI Holding A/S12
  3. Accenture A/S977

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Nicolaj Donskov Nielsen100%
Vilas Pharmaceutical Services ApS

Management

1 active registrations

Executive management

Executive management at Vilas Pharmaceutical Services ApS
NameRoleAppointed
Nicolaj Donskov NielsenCEO20/01/2014
Founders
Nicolaj Donskov Nielsen

Signing rule: Selskabet tegnes af en direktør

Address and production units

1 active production units

Vermehrensvej 8
4100 Ringsted

Ringsted Municipality · Postcode 4100

Production units
Production unitAddressEmployeesP number
VILAS PHARMACEUTICAL SERVICES ApSVermehrensvej 8, 4100 Ringsted21019074583

Purpose

Selskabets formål er rådgivning, handel og service samt aktiviteter i tilknytning hertil

The purpose is quoted from the register in Danish.

Changes year by year

10 registered events
20261 changeaccounts 1
  • Annual report for 2026 published
20252 changesaccounts 1 · industry 1
  • Annual report for 2025 published
  • Industry changed to Business and other management consultancy activities (702000)
20241 changeaccounts 1
  • Annual report for 2024 published
20231 changeaccounts 1
  • Annual report for 2023 published
20221 changeaccounts 1
  • Annual report for 2022 published
20211 changeaccounts 1
  • Annual report for 2021 published
20143 changesfounded 1 · management 1 · ownership 1
  • Registered as VILAS PHARMACEUTICAL SERVICES ApS
  • Nicolaj Donskov Nielsen appointed ceo
  • Nicolaj Donskov Nielsen registered as owner (100%)

Related companies

Same industry in Ringsted

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction